10
ANNUAL REPORT 2013-2014
ADVANCING THE BPS STRATEGIC PLAN
The well-structured, mixed FIP annual congress
Programme Committee has been and is preparing
balanced annual conferences where, as far as
possible, sessions profit from science and practice.
One of the highlights of this integrated approach
was the successful Dublin conference on meeting
the challenges of complex patients.
This congress was a natural follow-up to the FIP
centennial congress in Amsterdam, where the
responsible use of medicines was promoted: the
intelligent use of available treatments needs input
from practitioners and scientists. To get things
working, training and education are of high
importance.
On the level of the special interest and focus groups,
the BPS sponsored or co-sponsored local and regional
activities in several countries. At BPS level, support
to the Scientific Planning Committee for the 2014
Pharmaceutical Sciences World Congress in
Melbourne, Australia, helped get a high-level
conference programme together.
The next steps are the further development of
collaborations between BPS, Board of Pharmaceutical
Practice and FIP Education Initiative activities, all
with the aim of stimulating the responsible use of
medicines.
Henk de Jong
Scientific secretary
With the new structure of special interest and focus groups, the Board of Pharma ceutical Sciences (BPS) has worked to ensure that most of the pharmaceutical sciences fields are covered. Collaboration between practitioners, educators and scientists is, for FIP, a main strategic objective.
NOTES FROM THE BOARD OF PHARMACEUTICAL SCIENCES